| Primary |
| Bipolar Disorder |
23.3% |
| Schizophrenia |
19.7% |
| Depression |
18.7% |
| Major Depression |
6.7% |
| Psychotic Disorder |
5.3% |
| Schizoaffective Disorder |
3.8% |
| Anxiety |
3.6% |
| Bipolar I Disorder |
2.9% |
| Affective Disorder |
2.4% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Schizophrenia, Paranoid Type |
2.0% |
| Insomnia |
1.8% |
| Mania |
1.1% |
| Autism |
1.1% |
| Obsessive-compulsive Disorder |
1.0% |
| Bipolar Ii Disorder |
1.0% |
| Delusion |
1.0% |
| Post-traumatic Stress Disorder |
0.9% |
| Mood Swings |
0.9% |
| Agitation |
0.9% |
|
| Weight Increased |
19.0% |
| Tardive Dyskinesia |
14.6% |
| Tremor |
8.4% |
| Pregnancy |
7.0% |
| Akathisia |
5.8% |
| Dyskinesia |
4.6% |
| Drug Ineffective |
4.3% |
| Psychotic Disorder |
3.6% |
| Dystonia |
3.5% |
| Vision Blurred |
3.5% |
| Blood Glucose Increased |
3.2% |
| Vomiting |
2.8% |
| Restlessness |
2.7% |
| Somnolence |
2.7% |
| Death |
2.6% |
| Insomnia |
2.6% |
| Extrapyramidal Disorder |
2.5% |
| Mania |
2.3% |
| Weight Decreased |
2.1% |
| Adverse Event |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
16.6% |
| Depression |
15.7% |
| Schizophrenia |
11.7% |
| Bipolar Disorder |
11.2% |
| Drug Use For Unknown Indication |
10.3% |
| Anxiety |
5.6% |
| Psychotic Disorder |
4.6% |
| Schizoaffective Disorder |
3.9% |
| Attention Deficit/hyperactivity Disorder |
2.5% |
| Major Depression |
2.4% |
| Schizophrenia, Paranoid Type |
2.2% |
| Bipolar I Disorder |
2.0% |
| Insomnia |
1.8% |
| Affective Disorder |
1.5% |
| Hallucination |
1.4% |
| Personality Disorder |
1.4% |
| Delusion |
1.3% |
| Mania |
1.3% |
| Sleep Disorder |
1.3% |
| Post-traumatic Stress Disorder |
1.2% |
|
| Weight Increased |
21.3% |
| Tremor |
9.0% |
| Tardive Dyskinesia |
6.4% |
| Vomiting |
5.4% |
| Pregnancy |
5.2% |
| Psychotic Disorder |
5.0% |
| Suicidal Ideation |
4.9% |
| Somnolence |
4.8% |
| Suicide Attempt |
4.6% |
| Insomnia |
4.1% |
| Weight Decreased |
3.8% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Urinary Retention |
3.2% |
| Restlessness |
2.9% |
| Pulmonary Embolism |
2.9% |
| Vision Blurred |
2.8% |
| Akathisia |
2.6% |
| Drug Ineffective |
2.5% |
| Schizophrenia |
2.5% |
| Drug Hypersensitivity |
2.4% |
|
| Concomitant |
| Depression |
18.1% |
| Product Used For Unknown Indication |
15.5% |
| Bipolar Disorder |
14.3% |
| Schizophrenia |
8.9% |
| Anxiety |
7.6% |
| Drug Use For Unknown Indication |
4.6% |
| Sleep Disorder |
3.7% |
| Insomnia |
3.6% |
| Pain |
3.2% |
| Hypertension |
2.9% |
| Psychotic Disorder |
2.7% |
| Bipolar I Disorder |
1.8% |
| Smoking Cessation Therapy |
1.8% |
| Schizoaffective Disorder |
1.8% |
| Attention Deficit/hyperactivity Disorder |
1.7% |
| Affective Disorder |
1.6% |
| Schizophrenia, Paranoid Type |
1.6% |
| Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Asthma |
1.4% |
|
| Type 2 Diabetes Mellitus |
28.2% |
| Weight Increased |
17.6% |
| Pancreatitis |
6.7% |
| Vomiting |
5.9% |
| Suicidal Ideation |
4.9% |
| Diabetes Mellitus |
3.9% |
| Weight Decreased |
3.1% |
| Tardive Dyskinesia |
3.1% |
| Drug Ineffective |
2.7% |
| Tremor |
2.5% |
| Suicide Attempt |
2.4% |
| Type 1 Diabetes Mellitus |
2.4% |
| Vision Blurred |
2.4% |
| Rash |
2.3% |
| Pulmonary Embolism |
2.1% |
| Obesity |
2.1% |
| Somnolence |
2.1% |
| Depression |
2.0% |
| Nausea |
1.8% |
| White Blood Cell Count Decreased |
1.8% |
|
| Interacting |
| Product Used For Unknown Indication |
26.9% |
| Drug Use For Unknown Indication |
15.3% |
| Bipolar Disorder |
8.7% |
| Depression |
7.6% |
| Schizophrenia |
5.6% |
| Insomnia |
4.2% |
| Obsessive-compulsive Disorder |
4.0% |
| Attention Deficit/hyperactivity Disorder |
3.8% |
| Smoking Cessation Therapy |
3.3% |
| Osteoporosis |
2.7% |
| Vulvovaginal Candidiasis |
2.7% |
| Pain |
2.0% |
| Psychotic Disorder |
2.0% |
| Bipolar I Disorder |
1.8% |
| Major Depression |
1.8% |
| Affective Disorder |
1.6% |
| Anxiety |
1.6% |
| B Precursor Type Acute Leukaemia |
1.6% |
| Constipation |
1.6% |
| Fibromyalgia |
1.6% |
|
| Drug Interaction |
30.9% |
| Weight Increased |
11.8% |
| Tourette's Disorder |
7.4% |
| Vomiting |
6.6% |
| Neuroleptic Malignant Syndrome |
4.4% |
| Electrocardiogram Qt Prolonged |
3.7% |
| Hyperhidrosis |
3.7% |
| Rash |
3.7% |
| Haemodialysis |
2.9% |
| Hypothyroidism |
2.9% |
| Musculoskeletal Stiffness |
2.9% |
| Myoglobin Blood Increased |
2.9% |
| Tardive Dyskinesia |
2.9% |
| Dystonia |
2.2% |
| Parkinsonism |
2.2% |
| Suicide Attempt |
2.2% |
| Tremor |
2.2% |
| Abnormal Weight Gain |
1.5% |
| Extrapyramidal Disorder |
1.5% |
| Headache |
1.5% |
|
